Literature DB >> 15153560

Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.

Susanne Bro1, Flemming Moeller, Claus B Andersen, Klaus Olgaard, Lars B Nielsen.   

Abstract

Chronic renal failure markedly accelerates atherosclerosis in apolipoprotein-E-deficient mice, but the mechanism is unknown. The recruitment of inflammatory cells in the arterial wall by vascular adhesion molecules plays a key role in the formation of classical atherosclerosis. This study examines whether the expression of vascular adhesion molecules is increased in uremic atherosclerosis. Uremia was induced by 5/6 nephrectomy; control mice were sham-operated. After 2 wk of uremia, no lesion formation could be demonstrated in uremic or control mice. After 12 wk, aortas from uremic mice had a 9.8-fold increase of the aortic plaque area fraction compared with control mice (P < 0.0001). The aortic expression of intercellular adhesion molecule-1 (ICAM-1) mRNA in uremic mice was 215 +/- 31% (P < 0.05) and 243 +/- 55% (P < 0.05) of that in controls after 2 and 12 wk, respectively (n = 9 x 4). In contrast, aortic expression of vascular cell adhesion molecule-1 (VCAM-1) mRNA in uremic mice was unchanged after 2 wk but increased to 237 +/- 40% (P < 0.01) of that in control mice after 12 wk. On immunohistochemistry of aortas from uremic mice, ICAM-1 was predominantly present in endothelial cells both in nonlesioned and lesioned aortas, whereas VCAM-1 was predominantly present in the medial smooth muscle cell layer in lesioned aortas. The plasma concentration of soluble ICAM-1 (sICAM-1) (but not of sVCAM-1) was slightly elevated after 2 wk of uremia. In contrast, both sICAM-1 and sVCAM-1 plasma concentrations were markedly higher in uremic than control mice after 12 wk. These results suggest that uremic atherosclerosis is preceded by an upregulation of ICAM-1 expression in arterial endothelium and that formation of early uremic lesions is accompanied by upregulation of VCAM-1 expression in the medial smooth muscle cell layer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15153560     DOI: 10.1097/01.asn.0000128371.33195.7b

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  13 in total

1.  Dual inhibition of endothelial miR-92a-3p and miR-489-3p reduces renal injury-associated atherosclerosis.

Authors:  Carrie B Wiese; Jianyong Zhong; Zhi-Qi Xu; Youmin Zhang; Marisol A Ramirez Solano; Wanying Zhu; MacRae F Linton; Quanhu Sheng; Valentina Kon; Kasey C Vickers
Journal:  Atherosclerosis       Date:  2019-01-30       Impact factor: 5.162

2.  Lipoprotein(a) accelerates atherosclerosis in uremic mice.

Authors:  Tanja X Pedersen; Sally P McCormick; Sotirios Tsimikas; Susanne Bro; Lars B Nielsen
Journal:  J Lipid Res       Date:  2010-06-28       Impact factor: 5.922

3.  Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.

Authors:  Shuwang Ge; Barbara Hertel; Ekaterina K Koltsova; Inga Sörensen-Zender; Jan T Kielstein; Klaus Ley; Hermann Haller; Sibylle von Vietinghoff
Journal:  Circ Res       Date:  2013-08-01       Impact factor: 17.367

4.  Indoxyl sulfate induces leukocyte-endothelial interactions through up-regulation of E-selectin.

Authors:  Shunsuke Ito; Mizuko Osaka; Yusuke Higuchi; Fuyuhiko Nishijima; Hideto Ishii; Masayuki Yoshida
Journal:  J Biol Chem       Date:  2010-10-11       Impact factor: 5.157

Review 5.  Atherosclerosis in chronic kidney disease: the role of macrophages.

Authors:  Valentina Kon; MacRae F Linton; Sergio Fazio
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

6.  Expression of Vascular Cell Adhesion Molecule-1 in Peripheral Artery Disease is Enriched in Patients with Advanced Kidney Disease.

Authors:  Po-Tseng Lee; I-Chuang Liao; Cheng-Han Lee; Ling-Wei Hsu; Ping-Yen Liu
Journal:  Acta Cardiol Sin       Date:  2021-11       Impact factor: 2.672

7.  Iron sucrose accelerates early atherogenesis by increasing superoxide production and upregulating adhesion molecules in CKD.

Authors:  Ko-Lin Kuo; Szu-Chun Hung; Tzong-Shyuan Lee; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

8.  Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice.

Authors:  Line S Bisgaard; Markus H Bosteen; Lisbeth N Fink; Charlotte M Sørensen; Alexander Rosendahl; Christina K Mogensen; Salka E Rasmussen; Bidda Rolin; Lars B Nielsen; Tanja X Pedersen
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

9.  Darbepoetin alpha reduces oxidative stress and chronic inflammation in atherosclerotic lesions of apo E deficient mice in experimental renal failure.

Authors:  Nicole Arend; Karl F Hilgers; Valentina Campean; Britta Karpe; Nada Cordasic; Bernd Klanke; Kerstin Amann
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Effect of time on dialysis and renal transplantation on endothelial function: a longitudinal analysis.

Authors:  Joe Bueti; David Rush; Navdeep Tangri; Keren Mandelzweig; Yang Xu; Brett Hiebert; Manish M Sood; Paul Komenda; Peter Nickerson; Claudio Rigatto
Journal:  Transplantation       Date:  2014-11-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.